Search
Search Results
##search.searchResults.foundPlural##
-
ANTIFUNGAL PROPHYLAXIS IN IMMUNOCOMPROMISED PATIENTS
4462PDF: 1459HTML: 2207 -
OMENTAL SPLENOSIS MIMICKING PERITONEAL CARCINOMATOSIS
232PDF: 222HTML: 39 -
-
OUTLINE OF IRON METABOLISM, WITH EMPHASIS TO ERYTHROID CELLS iron Metabolism
2506PDF: 1383Html: 1103 -
INVASIVE FUNGAL INFECTION IN CHILDREN WITH ACUTE LEUKEMIA AND SEVERE APLASTIC ANEMIA IFI in Children with Acute Leukemia and SAA
2930PDF: 981HTML: 311 -
CMV MANAGEMENT WITH SPECIFIC IMMUNOGLOBULINS: A MULTICENTRIC RETROSPECTIVE ANALYSIS ON 92 ALLOTRANSPLANTED PATIENTS. Anti-CMV immunoglobulins for CMV treatment
2784PDF: 1258HTML: 289 -
SUSTAINED REMISSION IN AN ELDERLY PATIENT WITH ACUTE MYELOID LEUKEMIA FOLLOWING GILTERITINIB TREATMENT AS THIRD-LINE SALVAGE THERAPY Long-lasting disease remission with third line therapy with gilteritinib
1076PDF: 574HTML: 343 -
DEFERASIROX: OVER A DECADE OF EXPERIENCE IN THALASSEMIA
3292PDF: 1696HTML: 395 -
PROPHYLAXIS OF MALARIA
3128PDF: 1111HTML: 18068Figures SChwartz: 214 -
PREVALENCE OF SERIOUS BACTERIAL INFECTIONS IN CHILDREN WITH SICKLE CELL DISEASE AT KING ABDULAZIZ HOSPITAL, AL AHSA Bacterial infections in children with sickle cell diseas
1756PDF: 707HTML: 295 -
How we manage invasive fungal disease in acute myeloid leukemia patients with Glucose 6 Dehydrogenase deficiency
1923PDF: 975HTML: 1029Referring article: 802 -
THE GUT MICROBIOTA AND IMMUNE SYSTEM RELATIONSHIP IN HUMAN GRAFT-VERSUS-HOST DISEASE
6513PDF: 2238HTML: 14167Untitled: 252figure: 231 -
THE BIOLOGY OF MYCOBACTERIUM TUBERCULOSIS INFECTION.
11026PDF: 6585HTML: 21974 -
APPROPRIATE DURATION OF INTRAVENOUS TREATMENT OF CANDIDEMIA AND TIMING OF STEP DOWN TO ORAL THERAPY IN NON-NEUTROPENIC PATIENTS
3006PDF: 1178HTML: 500Preferred Reviewers: 254 -
THE ROLE OF INFECTION IN THE PATHOGENESIS OF VASO-OCCLUSIVE CRISIS IN PATIENTS WITH SICKLE CELL DISEASE.
5538PDF: 1420HTML: 2882Cover letter: 250 -
IMMUNOLOGY OF TUBERCULOSIS
5909PDF: 2349HTML: 7372Untitled: 251 -
Pseudo-differentiation syndrome
1531PDF: 731HTML: 10888Figure 1: peripheral blood showing myeloblasts with auer rods: 163Figure 2: CXR upon presentation to the hospital- no infiltrates nor consolidation changes: 147Figure 3: CXR showing pulmonary infiltartes with consolidation: 169Figure 4: CXR after starting steroid therapy- where the infiltrates have melted away: 154Figure 5: barograph showing the rising TLC ad ANC values- associated with worsening symptoms and increasing pulmonary infiltrates in CXR: 150 -
EFFICACY OF VENETOCLAX COMBINED WITH AZACITIDINE IN ELDERLY PATIENTS WITH RELAPSED ACUTE MYELOID LEUKEMIA
1612PDF: 864Suppl. Files: 368Html: 170 -
CANDIDA ASSOCIATED BLOODSTREAM INFECTIONS IN PEDIATRIC HEMATOLOGY PATIENTS: SINGLE CENTER EXPERIENCE
4543PDF: 993HTML: 1370Table1: 259 -
TUBERCULOSIS IN PATIENTS WITH HAEMATOLOGICAL MALIGNANCIES
3559PDF: 1339HTML: 8418 -
FROM LEGACY TO INNOVATION: PIDOTIMOD’S EXPANDING THERAPEUTIC HORIZON Pidotimod: Revisiting a Classic Immunomodulator
3145PDF: 1095HTML: 3018 -
DIAGNOSTIC ACCURACY OF CLINICAL TOOL ‘STOPS’ AND SERUM PROCALCITONIN FOR OPTIMIZING ANTIBIOTIC THERAPY IN NEONATAL SEPSIS STOPS and procalcitonin for optimizing antibiotics in neonatal sepsis
1907PDF: 667HTML: 494 -
Brief tale of a bacteraemia by Rhodococcus equi with concomitant lung mass: what came first, the chicken or the egg?
1500PDF: 885HTML: 8680Fig 3 Savini: 227Fig 2 Savini: 238Fig 1 Savini Chest TC: 234Author letter to referees: 238 -
ACQUIRED REFRACTORY IRON DEFICIENCY
3766PDF: 1298HTML: 1592 -
INFECTIOUS COMPLICATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA
3606PDF: 1470HTML: 2733 -
LETERMOVIR PRIMARY CYTOMEGALOVIRUS PROPHYLAXIS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS: COULD INFECTION AND DISEASE NO LONGER BE A SIGNIFICANT PROBLEM? Letermovir and Cytomegalovirus Prophylaxis in HSCT
1663PDF: 1096HTML: 148







